Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cue Health Reveals Strategic Actions; Names Clint Sever As CEO; Seeks To Refine And Strengthen Its Overarching Strategy And Cost Structure

Author: Benzinga Newsdesk | March 20, 2024 05:23pm
Clint Sever, co-founder and current Chief Product Officer, has been appointed CEO, effective immediately. Sever succeeds Ayub Khattak, who is stepping down as Chief Executive Officer, President, and Chairman. Khattak will remain a member of the Board of Directors. Cue will initiate a comprehensive review of the Company's business and operations, with a focus on assessing opportunities to refine and strengthen Cue's overarching strategy and cost structure. This review is intended to strengthen Cue's position for the future.

Posted In: HLTH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist